Patients undergoing treatment for lymphoma often experience adverse side effects that can be so severe that they stop or slow ...

Pfizer stock offers 30% upside with strong non-COVID franchises, margin expansion, and pipeline potential. Click here to read ...

By integrating HIV care with non-communicable disease prevention and care, healthcare systems can help people living with HIV ...

More than a year after its promised deadline to investors, drugmaker puts alarming results in federal government's "virtual ...

A variant in the IL-7 gene may predict which patients with kidney cancer are more likely to experience side effects from immunotherapy. A gene linked to immune system function may help predict which ...

Pfizer reported a dip in profits Tuesday, driven partly by lower sales of Covid-19 therapeutic drug Paxlovid, as it maintained a 2025 forecast that does not include potential tariff effects. Sales of ...

Anytime you try a new supplement, it’s important to have the right information so you’ll know about possible side effects. That’s true, too, for cannabidiol, also known as CBD. There are many CBD ...

Nirmatrelvir-ritonavir was beneficial for COVID-19 management in patients with chronic kidney disease or kidney failure, significantly reducing the risk of mortality and hospital admission. Paxlovid ® ...

DEAR DR. ROACH: I foolishly was in a crowded indoor location and got COVID (for the third time). I thought about getting Paxlovid. But I figured, heck, I’m healthy and vaccinated; I’ll just tough it ...

Paxlovid, the five-day antiviral treatment for covid, may not reduce the risk of covid-related hospitalizations and all-cause deaths in vaccinated older adults, a new study suggests. Paxlovid - Pfizer ...